Cao Y, Xia Q, Liang J, Wang J, Shan F, Dai B
Neuropsychiatr Dis Treat. 2024; 20:1563-1570.
PMID: 39156033
PMC: 11330252.
DOI: 10.2147/NDT.S473973.
Lenoir C, Rollason V, Desmeules J, Samer C
Front Pharmacol. 2021; 12:733935.
PMID: 34867341
PMC: 8637893.
DOI: 10.3389/fphar.2021.733935.
Huang K, Kuo W, Kuan Y, Chang Y, Tsai T, Lee C
Int J Med Sci. 2021; 18(15):3565-3573.
PMID: 34522183
PMC: 8436093.
DOI: 10.7150/ijms.63246.
Mustafa F
Psychopharmacol Bull. 2020; 50(3):119-124.
PMID: 32733115
PMC: 7377545.
Gisi C, Munteanu A, Ku L, French S, Fleischman M, Eysselein V
Case Rep Gastrointest Med. 2020; 2020:1272567.
PMID: 32670642
PMC: 7333039.
DOI: 10.1155/2020/1272567.
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.
De Leon J, Ruan C, Schoretsanitis G, De Las Cuevas C
Psychother Psychosom. 2020; 89(4):200-214.
PMID: 32289791
PMC: 7206357.
DOI: 10.1159/000507638.
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.
Man W, Wilting I, Heerdink E, Hugenholtz G, Bognar T, Ten Berg M
Clin Pharmacokinet. 2019; 58(8):1069-1075.
PMID: 31111332
PMC: 6614135.
DOI: 10.1007/s40262-019-00744-6.
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.
Li Y, Su R, Xu S, Huang Q, Xu H
Neuropsychiatr Dis Treat. 2017; 13:2477-2487.
PMID: 29026311
PMC: 5627760.
DOI: 10.2147/NDT.S145069.
Elevated clozapine plasma concentration secondary to a urinary tract infection: proposed mechanisms.
Lee L, White R, Barr A, Honer W, Procyshyn R
J Psychiatry Neurosci. 2016; 41(4):E67-8.
PMID: 27332768
PMC: 4915939.
DOI: 10.1503/jpn.150156.
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.
Gee S, Dixon T, Docherty M, Shergill S
BMC Psychiatry. 2015; 15:195.
PMID: 26265348
PMC: 4542109.
DOI: 10.1186/s12888-015-0536-4.
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels.
Hefner G, Shams M, Unterecker S, Falter T, Hiemke C
Psychopharmacology (Berl). 2015; 233(9):1695-705.
PMID: 26032842
DOI: 10.1007/s00213-015-3976-0.
Burning pain secondary to clozapine use: a case report.
Linton B, Fu R, MacDonald P, Ganjavi H
BMC Psychiatry. 2014; 14:299.
PMID: 25339121
PMC: 4210481.
DOI: 10.1186/s12888-014-0299-3.
Infections and possible vaccine-drug interactions.
Raaska K, Neuvonen P
Eur J Clin Pharmacol. 2014; 70(7):889-90.
PMID: 24801149
DOI: 10.1007/s00228-014-1688-8.
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?.
Remington G, Agid O, Foussias G, Ferguson L, McDonald K, Powell V
Psychopharmacology (Berl). 2012; 225(3):505-18.
PMID: 23179967
DOI: 10.1007/s00213-012-2922-7.
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.
Klein K, Winter S, Turpeinen M, Schwab M, Zanger U
Front Pharmacol. 2011; 1:129.
PMID: 21918647
PMC: 3171976.
DOI: 10.3389/fphar.2010.00129.
Interaction of clozapine and ciprofloxacin: a case report.
Sambhi R, Puri R, Jones G
Eur J Clin Pharmacol. 2007; 63(9):895-6.
PMID: 17624521
DOI: 10.1007/s00228-007-0313-5.
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Jaquenoud Sirot E, van der Velden J, Rentsch K, Eap C, Baumann P
Drug Saf. 2006; 29(9):735-68.
PMID: 16944962
DOI: 10.2165/00002018-200629090-00001.
Toxic clozapine serum levels during acute urinary tract infection: a case report.
Jecel J, Michel T, Gutknecht L, Schmidt D, Pfuhlmann B, Jabs B
Eur J Clin Pharmacol. 2005; 60(12):909-10.
PMID: 15657777
DOI: 10.1007/s00228-004-0867-4.